Manipal Hospitals Slashes IPO Valuation to $8.3 Billion Amid Global Market Turbulence

Manipal Hospitals Slashes IPO Valuation to $8.3 Billion Amid Global Market Turbulence

Manipal Hospitals Slashes IPO Valuation to $8.3 Billion Amid Global Market Turbulence​

Manipal Health Enterprises Ltd., the prominent operator of the Manipal Hospitals chain, is reportedly revising its valuation downward for its upcoming initial public offering.

The company is now seeking a valuation of approximately Rs 80,000 crore ($8.3 billion) for the listing. This move marks a significant pivot from the $10 billion to $12 billion range originally floated in April.

Market sources indicate that the revision reflects a more cautious investor sentiment currently pervading large public offerings. This shift comes as heightened tensions in the Middle East continue to spark turbulence across global financial markets.

Strategic Valuation Adjustment and Listing Timeline​

The Temasek Holdings Pte.-backed entity plans to raise as much as Rs 11,000 crore through a share sale. The offering is expected to launch during the week starting July 27.

Despite the valuation haircut, the proposed listing remains poised to be India's largest IPO of 2026 so far. It is set to surpass the $1 billion IPO launched by SBI Funds Management Ltd. this week.

Internal deliberations remain ongoing, and stakeholders have noted that details regarding the final valuation, offering size, and timing are still subject to change. A representative for Manipal Hospitals did not respond to requests for comment.

Issue Structure and Capital Allocation Plans​

The IPO is structured to include a fresh issue of shares worth approximately 80 billion rupees. Additionally, there will be an offer for sale of up to 43.23 million shares by existing shareholders, including TPG Inc.

According to the draft prospectus, the company intends to deploy the proceeds from the primary issue toward strategic growth and stability. These funds are earmarked to repay debt, fund critical capital expenditure, and support the group's expansion plans.

High-Profile Institutional Advisory Support​

Manipal Health is collaborating with a powerhouse group of financial institutions to manage the proposed offering. The company is working with Kotak Mahindra Capital Co. and Axis Capital Ltd.

The listing also features prominent global investment banks, including the Indian units of Goldman Sachs Group Inc., JPMorgan Chase & Co., Jefferies Financial Group Inc., UBS Group AG, and DBS Bank Ltd.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Back
Top